Indian company VINS Bioproducts and German company Neovii Biotech will work together on immunoglobulin medicines.
Key product is anti‑thymocyte globulin, used for organ transplants and certain blood conditions.
Collaboration includes sharing manufacturing technology with India.
Goal is to boost domestic production and lower reliance on imports.
The focus includes anti‑thymocyte globulin, a drug used in organ transplantation and specific blood disorders.
The agreement involves technology transfer to enable local manufacturing in India.
This aims to strengthen India's capacity and reduce dependence on imported medicines.
Want to learn even more? Click here to read the full story!